These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7981638)

  • 1. Quinolinic acid but not MK-801 protects the dopaminergic system from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced toxicity in goldfish retina.
    Guarnieri T; Virgili M; Carraro S; Villani L
    Neurochem Int; 1994 Jun; 24(6):559-64. PubMed ID: 7981638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.
    Zuddas A; Oberto G; Vaglini F; Fascetti F; Fornai F; Corsini GU
    J Neurochem; 1992 Aug; 59(2):733-9. PubMed ID: 1629743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats.
    Sonsalla PK; Zeevalk GD; Manzino L; Giovanni A; Nicklas WJ
    J Neurochem; 1992 May; 58(5):1979-982. PubMed ID: 1560247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss.
    Srivastava R; Brouillet E; Beal MF; Storey E; Hyman BT
    Neurobiol Aging; 1993; 14(4):295-301. PubMed ID: 8103573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in goldfish brain.
    Poli A; Guarnieri T; Facchinetti F; Villani L
    Brain Res; 1990 Nov; 534(1-2):45-50. PubMed ID: 1981485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
    Michel PP; Agid Y
    Brain Res; 1992 Dec; 597(2):233-40. PubMed ID: 1361874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine hydroxylase immunohistochemistry in the normal and 1-methyl-4-phenyl-tetrahydropyridine (MPP+)-treated retina of goldfish.
    Guarnieri T; Villani L; Fasolo A
    Neurosci Lett; 1989 Dec; 106(3):269-74. PubMed ID: 2574839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice.
    Chan P; Di Monte DA; Langston JW; Janson AM
    J Pharmacol Exp Ther; 1997 Jan; 280(1):439-46. PubMed ID: 8996226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice.
    Tabatabaei A; Perry TL; Hansen S; Krieger C
    Neurosci Lett; 1992 Jul; 141(2):192-4. PubMed ID: 1436633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice.
    Zuddas A; Vaglini F; Fornai F; Fascetti F; Saginario A; Corsini GU
    Ann N Y Acad Sci; 1992 May; 648():268-71. PubMed ID: 1386204
    [No Abstract]   [Full Text] [Related]  

  • 13. 6,7-Dinitroquinoxaline-2,3-dione but not MK-801 exerts a protective effect against kainic acid neurotoxicity in the goldfish retina.
    Villani L; Carraro S; Guarnieri T
    Neurosci Lett; 1995 Jun; 192(2):127-31. PubMed ID: 7675320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro.
    Finiels-Marlier F; Marini AM; Williams P; Paul SM
    J Neurochem; 1993 May; 60(5):1968-71. PubMed ID: 8473912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L; Thedinga KH; McVey M; Fagg GE
    Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY; Albers DS; Sonsalla PK
    Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice.
    Kupsch A; Löschmann PA; Sauer H; Arnold G; Renner P; Pufal D; Burg M; Wachtel H; ten Bruggencate G; Oertel WH
    Brain Res; 1992 Oct; 592(1-2):74-83. PubMed ID: 1360317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.
    Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K
    Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.